Computer simulations were performed on models of the β 2 -adrenergic receptor dimer, including 5,6-domain swapped dimers which have been proposed as the active, high affinity form (here the dimer interface lies between helices 5 and 6). The calculations suggest that the domain swapped dimer is a high energy structure in both the apo dimer and in the presence of propranolol. In the presence of agonist the energy of the domain swapped dimer is significantly lowered. Analysis of the dimer structure suggests that the agonist-induced conformational change optimizes the helix-helix interactions at the 5-6 interface. An antagonist on the other hand has little effect on these interactions. These observations are consistent with the hypothesis that the agonist functions by shifting the equilibrium in favour of the domain swapped dimer. Indirect support for the domain swapping hypothesis was obtained from the correlated mutations amongst the external residues of the known β 2 -adrenergic receptors. These occur mainly at the 5-6 interface at precisely the locations predicted by the simulations; site-directed mutagenesis data in support of a functional role for these lipid-facing correlated residues is presented.
Introduction
Domain swapping is an important mechanism which may be used for extending the functional repertoire of dimeric proteins (Bennett et al., 1994 (Bennett et al., , 1995 Tegoni et al., 1996; Cameron et al., 1997; Gouldson et al., 1997a,b,c,d; Schlunegger et al., 1997; Larsen et al., 1998) . Although domain swapping has not to our knowledge been explicitly mentioned by others in the context of G-protein coupled receptors (Baldwin, 1994; Watkinson, 1994; Guddermann et al., 1997) , recent experiments (Maggio et al., 1993a (Maggio et al., , 1996 Ciruela et al., 1995; Hebert et al., 1996; Romano et al., 1996; Cvejic and Devi, 1997) have suggested that dimerization is important. Some of the more compelling evidence for dimerization is related to the role of dimers in functional rescue (Maggio et al., 1993a (Maggio et al., , 1996 Monnot et al., 1996) , but as yet there is no definitive evidence on the role of dimers in activation. Since there is currently much debate on the role of dimers in G-protein coupled receptors, we present here a preliminary correlated mutation analysis (Göbel et al., 1994; Singer et al., 1995; Pazos et al., 1997) and molecular dynamics (Karplus and Petsko, 1990 ) investigation of various possible β 2 -adrenergic receptor (Main, 1990; Timmermans et al., 1990) dimers to determine whether such models are consistent with current experimental understanding of the activation process.
There have been many illuminating studies of the conformational changes involved in activation of the G-protein coupled receptors. These have included computational simulations (Zhang et al., 1993; Luo et al., 1994; Sheer et al., 1996; Gouldson et al., 1997a) , site-directed spin labelling studies (Farabakhsh et al., 1995; Altenbach et al., 1996; Farrens et al., 1996) , substituted cysteine accessibility studies on constitutionally active receptors (Javitch et al., 1997) and fluorescence studies on constitutive and agonist induced activation (Gether et al., 1995 (Gether et al., , 1997a . Many of these studies highlight changes in helices six, but also changes in helices three and five. Kobilka et al. (1988) and Maggio et al. (1993b) observed reassociation and subsequent activity when receptors were split between helices five and six and then coexpressed. These functional rescue studies involved the receptors domains in much larger relative movements. Similar results confirming the dynamic nature of the receptor domains were obtained by Schöneberg et al. (1995) and Monnot et al. (1996) .
All this work must be seen against a background where there is no widely accepted understanding of the activation process at the molecular level. Consequently, many phenomena associated with G-protein coupled receptors, such as partial agonism, inverse agonism, high and low affinity states of the receptor, autoactivation and constitutive activation have no clear explanation.
The dimerization theory may shed light on many of these processes. For example, our knowledge of high and low affinity forms is indicative of a conformational change in the receptor, but when Potter et al. (1991) observed that only 50% of dopamine D 2 receptors were in their high affinity forms at any one time, this pointed towards dimerization. Indeed, for a while there has been much circumstantial evidence for dimerization. Here we will simply list some of the evidence but a discussion of how this may relate to dimerization will be deferred until the discussion. The evidence includes the autoactivation of G-protein coupled receptors when overexpressed in transgenic mice (Bond et al., 1995) , the activation of receptors by both bivalent antibodies (Leiber et al., 1984) and by antagonists coupled back to back (Hazum and Keinan, 1981) , the particularly strong activation of G-proteins obtained by coupling together two copies of peptides from intracellular loop three (Wade et al., 1994) , the observation of dimers in the two-dimensional projections maps of rhodopsin (Corless et al., 1982; Schertler et al., 1993; Unger and Schertler, 1995) , bell-shaped dose response curves (Järv, 1995) , the Maggio et al.'s (1993a) inactive chimeric receptors forming a 1,7-dimer. Also shown are two intermediates on the domain swapping pathway and the active 5,6-domain swapped dimer.
immunological studies of Ciruela et al. (1995) , the identification of SDS-resistant dimers by Hebert et al. (1996) and the observation that peptides derived from transmembrane helix six (Hebert et al., 1996) can inhibit G-protein activation; peptides derived from helix seven have been shown to inhibit dimerization (Ng et al., 1996) . The most illuminating evidence however comes from the observations of Maggio et al. (1993a Maggio et al. ( , 1996 who prepared chimeric receptors where the N-terminus and helix one through to helix five was taken from the muscarinic M 3 receptor while helices six and seven through to the C-terminus were taken from the α 2 -adrenergic receptor. The receptor was found to be inactive, as was the alternative adrenergic-muscarinic chimera (in both chimeras, intracellular loop three was taken from the muscarinic receptor). However, when the two chimeras were coexpressed, they were able to activate G-proteins but no precise molecular explanation was given. Elsewhere (Gouldson and Reynolds, 1997; Gouldson et al., 1997a,c,d) we have proposed that this may be explained by the domain swapping mechanism shown in Figure 1 (discussed below) and here we analyse this mechanism to identify areas where it may be compatible with our understanding of G-protein coupled receptor activation derived from experiment.
Correlated mutation analysis (Göbel et al., 1994; Singer et al., 1995; Pazos et al., 1997 ) is a method of probing for structurally significant residues in proteins with a similar fold and function. It involves systematically searching for highly correlated patterns of change through a set of aligned sequences. It therefore highlights those positions in the sequence concerned with the finer details of intermolecular interactions such as those involved in specificity. In particular, it indicates where a mutation in one area may be compensated by a mutation in another, as shown for example in the ligand binding studies on serotonin (Kuipers et al., 1994) , dopamine (Bywater et al., 1182 (Bywater et al., 1995 glucagon-like receptors (Horn et al., 1998) and in an analysis of subtype specificity in the adrenergic, muscarinic and dopamine receptors (Gouldson et al., 1997e) . In the adrenergic receptors, if the receptor only made non-specific interactions with the lipid we would expect no external correlated mutations. However, one of the exciting observations to emerge is that a large number of external correlated mutations were observed (Gouldson et al., 1997d) . Here, it is important to note that gene sequences are experimental data and so these data are complementary to that from the protein modelling.
Methods
The β 2 -adrenergic receptor model In order to carry out the computer simulations and to interpret the correlated mutation analysis, we have constructed a model of the β 2 -adrenergic receptor. The model is based on a multiple sequence alignment involving rhodopsin in the β 1 -, β 2 -and β 3 -adrenergic receptors and a rhodopsin template based on the electron cryomicroscopy projection structure of rhodopsin (Unger and Schertler, 1995) . The receptor model containing propranolol is in agreement with the recent rhodopsin electron cryomicroscopy projection structure -the root mean square deviation from the corresponding transmembrane alpha carbon coordinates is 2.5 Å in the central regions, increasing to about 3.8 Å when the helix ends are included. This agreement is within the resolution of the experimental structure, particularly bearing in mind that the two receptors are different. The rotational orientation of each helix in our model is in agreement with Baldwin's to within about 10°. The vertical displacement of the alpha carbons of the conserved residues is in agreement to within approximately 2Å. The agreement with the agonist-bound model is, as expected, not as good. The r.m.s. deviation of alpha carbons is 5.6Å and there are probably two additional reasons for this. Firstly, the experimental rhodopsin structure is an inactive form and secondly large helical movements of up to 8Å have been observed on activation (Gouldson et al., 1997) .
In constructing this model, we followed the lead of Hubbard (1995, 1996) by incorporating a range of experimental and other data including information from the helix prediction algorithm of Rost (1996) and from site-directed mutagenesis data on both rhodopsin and the β 2 -adrenergic receptor. The latter was largely used to determine the inward facing residues, but clearly this approach has been followed cautiously as one of our main messages in this article is that external transmembrane residues may have a genuine function. The model was refined by minimization and molecular dynamics using the AMBER software (Singh et al., 1988) . The antagonist (propranolol) and the agonist (norepinephrine) were docked into the receptor using our novel domain-based docking strategy (Gouldson et al., 1997a) and the results were found to conform with the site-directed mutagenesis results. The results of Suryanarayana et al. (1991 Suryanarayana et al. ( , 1993 in particular suggest that the antagonist binds between the conserved aspartate on helix three, the hydrophobic pocket between helices one, two (and three) and a key residue on helix seven, namely Asn 312 . This site is referred to as the antagonist binding site. The agonist binding site on the other hand lies between the conserved Asp 113 on helix three and conserved serines on helix five (Ser 204 and Ser 207 ) while making contact with helix seven (Leu 311 ) and an alternative hydrophobic pocket formed by residues on helix six (Trp 286 and Phe 290 ) and three (Gouldson et al., 1997a) . The observation that mutation of residues homologous to Asn 312 in the antagonist binding site of related receptors only affects some antagonist binding (Wess et al., 1991) may be an indication that not all antagonists bind to the 'antagonist' binding site. Moreover, mutation of residues in the agonist binding site may affect antagonist binding (Wess et al., 1993; Bluml et al., 1994) . Thus, it is possible that some antagonists bind in the agonist binding site but this is probably not the case here.
The receptor model and docking methodology are fully described elsewhere and the coordinates have been deposited as supporting information (Gouldson et al., 1997a- this article contains 115 references). Molecular dynamics simulations on the dimers Three dimers were selected for further study: (i) the 1,2-dimer, because this appears to be the structure observed in the twodimensional electron diffraction maps of rhodopsin (Corless et al., 1982; Schertler et al., 1993) ; (ii) the 5,6-domain swapped dimer, which we have proposed to explain the results of Maggio et al. (1993a) ; and (iii) the 1,7-dimer, which we have proposed as a possible intermediate on the domain swapping pathway which could be formed by a slight rearrangement of the 1,2-dimer. The 1,2-dimer is best referred to as a contact dimer since the contact point between the two receptor monomers involves helices one and two of the first receptor contacting helices two and one, respectively, of the other monomers (Figure 2a) . The 1,7-dimer is similar in that helices one and seven contact helices seven and one respectively of the other monomer, as shown in Figure 1 (top left) and Figure 2b . In both of these contact dimers there is no covalent link across the dimer interface. The 5,6-domain swapped dimer shown in Figure 1 (bottom right) and Figure 2c is more 1183 complicated. A superficial glance at only the transmembrane helices would suggest that the dimer interface is between helices five and six. However, since the B domain (comprised of helices six and seven and the associated loops) of each monomer is swapped out and replaced by the B domain of the other monomer, the dimer interface is actually much larger, as shown in Figure 2c and the bottom right of Figure 1 . To all intents and purposes, the transmembrane bundle of the domain swapped dimer has the same interactions as the monomerbut the loops have new interactions and these will be different in the contact dimer and the domain swapped dimer. (Here we note that our simulations only consider the interactions between the transmembrane helices so the 5,6-domain swapped dimer referred to here is essentially the same as the 5,6-contact dimer.)
The simulations on the dimers (or dimer plus one ligand molecule) were performed using the all-atom AMBER force field (Weiner et al., 1984 (Weiner et al., , 1986 within the AMBER 4.1 suite of programs (Singh et al., 1988) . The simulations were run at 298 K using a non-bonded cut-off of 10 Å and a time step of 0.0005 ps. A distance-dependent dielectric constant was used since the environment within the receptor is intermediate between bulk water and the interior of a protein (Gouldson et al., 1995) . The dimer structures were generated by releasing the system in the appropriate orientation with the monomers initially separated by 9 Å. A similar strategy was used for docking the ligands into the GPCR. This involved docking the ligands onto the A domain and simulating the reassociation of the B domain from a distance of about 6 Å during the course of a molecular dynamics simulation; this strategy yielded complexes which are very well supported by experiment (Gouldson et al., 1997a) .
The systems were gently heated and equilibrated for 27 ps according to the protocol described by Gouldson et al. (1997a) and then equilibrated for a further 40 ps at 298 K. (The final structure was essentially formed during the first 20 ps but the energies required at least 50 ps to settle down.) The simulations were then run for at least 400 ps.
Free energy simulations
To assess whether our dimer models are consistent with the known experimental site-directed mutagenesis information on residues believed to lie at the dimer interface (Huang et al., 1994; Hebert et al., 1996) , we carried out the corresponding mutations during the course of a free energy difference simulation (Beveridge and DiCapua, 1989; Reynolds et al., 1992) on a 5,6-6,5 four helix bundle taken from the 5,6-dimer interface. The helix bundle was equilibrated for 20 ps at 10 K, 20 ps at 100 K and 100 ps at 298 K using SHAKE (van Gunsteren and Berendsen, 1977) and a time step of 0.001 ps. The G276A, G280A and L284A mutations (Hebert et al., 1996) were carried out concurrently and the free energy change was computed using the windowing approach which is based on the exponential formula (Zwanzig, 1954) :
Here, ∆G AB is the free energy difference between states A and B, ∆H AB is the corresponding molecular mechanics energy difference, and Ͻ...Ͼ A means that the average of exp(-∆H AB / RT) is evaluated over the configuration of state A. In practice, ∆H AB must be small to ensure convergence and so the overall mutation was split into 21 'windows' with each subsequent window corresponding to an extra 5% of the mutation. Each window consisted of 10 000 steps of equilibration followed by 10 000 steps of data collection; the mutation therefore occurred over a period of 420 ps which is comparable to the length of the simulations described above. This simulation was also run on the fully equilibrated 14 helix 5,6-dimer but only 500 steps of equilibration and 500 steps data collection were carried out for each window. The Y209A mutation (Huang et al., 1994 ) was much more difficult as it represents a significant reduction in size and severe difficulties were encountered in evaluating the derivatives for the dummy atoms used to represent the disappearing atoms (Reynolds et al., 1992) . Such mutations are usually carried out using Monte Carlo (MC) methods as MC does not require derivatives. However, MC methods are not so useful in protein simulations. Consequently, the mutation was carried out in three stages: (i) Tyr → Phe, (ii) Phe → Ala* and (iii) Ala* → Ala where Ala* represents an alanine with an unusually large C β such that the Phe → Ala* mutation results in essentially no volume change; dummy atoms not required in the next stage were eliminated to minimize the number of dummy atom derivatives required [thus the dummy atoms formed from the Tyr OH group during the Tyr → Phe mutation were not required for stage (ii)]. Each mutation was carried out in 21 windows, as described above, and so the total duration of the mutation was 1.25 ns. Free energy is a state function and so the total free energy change is still meaningful even though the mutation was carried out via the hypothetical amino acid Ala*. The additional force field parameters used in the free energy simulations are available from the authors by request.
Correlated mutation analysis
The adrenergic receptor sequences used were obtained from the GPCRDB database (Vriend) ; this is a G-protein coupled receptor database website. The alignments were obtained using the profile alignment method in the protein modelling program WHATIF which is similar to that of Sander and Schneider (1991) . The GPCRDB mnemonics for the sequences are given in Table I . Pazos et al. (1997) warn that at least 15 sequences with reasonable diversity are usually required for a reliable CMA and here we have used 52 sequences spanning all the adrenergic receptor subtypes. CMA may be more appropriate for GPCRs than for many other proteins because (i) so many sequences are available; (ii) they have a similar fold, particularly in the transmembrane region which is the focus of this study; and (iii) the ligand binding site has the characteristics of a domain boundary because GPCRs consist of two domains, as shown in Figures 1 and 2 (see Oliveira et al., 1993; Singer et al., 1995; Horn et al., 1998 for interesting applications of CMA to GPCRs). The significance level for reporting the correlated mutations corresponded to a correlation coefficient of 0.975, though some correlations occurring below this level are discussed. (This means that a small percentage of the reported residues may be statistical anomalies rather than residues that have genuinely mutated in a correlated manner. For this reason, it is beneficial to couple a correlated mutation analysis with other techniques such as molecular modelling or site-directed mutagenesis.) The correlation coefficients, r ij , for the pairwise comparison of sequence positions i and j is defined fully elsewhere (Singer et al., 1995) . This equation is based on sequence alone and is very similar to other implementations of correlated mutation analysis which have yielded positive results on problems related to protein folding (Göbel et al., 1994; Brenner 1995; Pazos et al., 1997; Ortiz et al., 1998) ; an alternative approach, b3ar-rat 52 b4ar-melga as followed by Taylor et al. (1994 Taylor et al. ( , 1997 , is to build in amino acid properties such as volume or hydrophobicity which may be related to the underlying physical properties in correlated mutations which also have a compensatory nature. However, this alternative approach has not been as successful and this may be because compensatory mutations do not necessarily occur in the protein core as alternative mechanisms for alleviating strain are possible-see for example Lesk and Chothia (1980) , van Gunsteren and Mark (1992) , Hubbard et al. (1994) , Horn et al. (1998) . Correlated mutations became particularly useful when it was realized by Oliveira et al. (1997) and Horn et al. (1998) that above all it is the function that must be considered, and that to achieve this mutations at domain boundaries (where binding and catalytic sites typically reside), rather than in protein cores, must be compensated for. Interestingly, mutations related to function have also been detected at protein-protein interfaces which are similar to domain interfaces (Horn et al., 1998) . Elsewhere, Pazos et al. (1997) has shown that correlation mutation analysis can be used to single out the right interdomain docking solution amongst many alternatives for two domain proteins. Consequently, we have implemented their harmonic average (Xd) according to their formula
where P ic is the percentage of inter-monomer correlated pairs with distance between d i and d i-1 and P ia is the same percentage for all pairs of positions. Here d i represents the upper limit of one of n distance bins and each bin has a span of 4 Å. The difference between the two percentages is weighted by a factor inversely proportional to the distance of the corresponding bin to increase the weight of closer distances. The position of each amino acid is determined from the coordinates of the C β except in the case of glycine where the C α coordinates were used.
The correlated mutation analysis, the determination of changes in surface accessible area and much of the interactive modelling were performed using the WHATIF protein modelling software . The residue numbers reported are for the human β 2 -adrenergic receptor.
Results
The energies obtained from the molecular dynamics simulations are shown in Figure 3 . Figure 3a shows the potential energy for the three dimer structures in the absence of ligand. Figure 3b shows the potential energy for the alternative dimer structures containing one mole of antagonist (propranolol) and Figure 3c shows the corresponding energies in the presence of one mole of agonist (norepinephrine). For clarity, the energies were dumped every 0.5 ps and displayed as the average over the previous 10 ps. Figure 4 shows the correlated residues displayed on a snake diagram. It also shows the residue-residue interactions at the 5-6 interface, identified either from their interaction energy or using the WHATIF molecular graphics software. The helixhelix packing angles at the interface are generally around the optimum value of ϩ23°proposed by Chothia et al. (1981) and indeed the interactions at the 5-6 interface generally belong to the class 3-4 set of interactions where sidechains separated by three residues form a series of ridges which lie in the grooves formed between ridges separated by four residues; this pattern is most readily observed by viewing only the C β atoms of the interfacial sidechains. The same general pattern is observed in all three 5-6 domain swapped dimers but in each case the packing is asymmetric. Moreover, the agonist induces rotation and a displacement perpendicular to the membrane plane in both helices 5 and 6 and this is observed in both the monomer (Gouldson et al., 1997a) and the dimer. Consequently, the precise identity of the residue comprising the ridges and grooves at the interface is different in all three 5,6-domain swapped dimers, as recorded in Table II . The structures are however related by translation along the grooves.
The accessible surface area of each interfacial residue in the various 5,6-domain swapped dimer structures is shown in Figure 5 and so this figure may be used to identify the residues making contact at the interface. Here it is apparent that the 4. (a) A snake diagram of the β 2 -adrenergic receptor displaying the correlated residues which occur at a correlation cut-off value of 0.975 or higher (see also Table IV ). The diagram also shows the key interactions at the 5-6 interface of the domain swapped dimer, as identified using spatial and energetic criteria. The conserved residues are denoted by black circles, with an uppercase letter to denote residues identified as external; the correlated residues are denoted by grey circles with a white letter to denote residues identified as external. (b) The corresponding results for a correlation cut-off value of 0.95 or higher.
residues are generally less accessible at the intracellular end of helices 5 and 6 and indeed the closer contacts in this region are apparent from a molecular graphics analysis. The interfacial residues in the antagonist-bound dimer generally have the 1186 highest accessibilities. The results in Figures 4 and 5 were determined by averaging the structures generated at 50 ps intervals.
The free energy differences are reported in Table III . In The ridges and grooves are denoted by the symbols r and g respectively; the spacing between the residues is indicated by the prefix 3 or 4. A groove is formed between the two ridges denoted 3g or 4g. Fig. 5 . The surface accessible areas for the residues at the 5,6-domain swapped dimer interface-for the apo dimer, the agonist-bound dimer and the antagonist-bound dimer. The average accessibilities of these residues in the protein databank are also shown. both cases, G276A;G280A;L284A and Y209A, the free energy change for the mutations is positive. One could infer from the experiments that the effect of these mutations is to destabilize the dimer interface, and a positive free energy change is consistent with this. (In the case of the G276A;G280A;L284A mutation, the experimental information is indirect because mutation of the helix 6 peptide in the β 2 -adrenergic receptor system meant that the peptide could no longer disrupt dimer formation.) The observation of a positive free energy for these mutations calculated with a model similar to the one used for the dimer simulation results presented in Figure 3 goes some 1187 way to supporting our choice of atomistic model to represent the dimer.
The correlated mutation analysis identified a large number of internal residues as expected and these are discussed elsewhere (Gouldson et al., 1997e) , but interestingly, a number of correlated mutations were also found amongst the external residues and these are presented in Table IV . As shown in Figure 4 , the correspondence between the interfacial residues identified using the spatial or energetic criteria and the correlated mutations is quite high. (Fewer contacts are shown in Figure 4 than in Figure 5 because not all of the contacts in The simulations were performed on the four helix bundle representing the 5,6-dimer interface unless indicated otherwise. The error bars given represent the difference between forward and reverse sampling (Reynolds et al., 1992) . a Simulation performed on full 5,6-dimer. b The total free energy change for the Y209A mutation is 3.7Ϯ0.5 kcal mol -1 . Table IV . The full network of correlated mutations, identified using a correlation level of 0.975 or higher Both the β 2 and the universal numbering scheme of Oliveira et al. (1993) are used.
the apo or antagonist-bound dimers are preserved in the agonist-bound dimer. Likewise, many of the residues which contribute to the interfacial ridges or grooves do not make serious contacts in the dimer because the side chain points away and these do not appear in Figure 4 .) The Xd values (Pazo et al., 1997) are -0.23 and -0.26 for the 1,2-and 1,7-dimer in the presence of antagonist-an antagonist has essentially no effect on the structure (Gouldson et al., 1997) and ϩ0.13 for the 5,6-dimer in the absence of ligand; this goes up to ϩ0.38 in the presence of agonist. The value of Xd is relatively insensitive to the correlation cut-off value chosen; moreover the same qualitative picture is retained if the conserved residues are included in the Xd analysis.
Discussion

Energetics, agonism and domain swapping
The main evidence for domain swapping comes from the chimeric studies of Maggio (1993a) and the double mutant studies of Monnot (1996) . If we assume that the 5,6-domain swapped dimer is the high affinity active form, the results in Figures 1 and 3 give us a new framework for discussing receptor activation. In Figures 3a and b the mean energy of the 5,6-domain swapped dimer from 50 to 100 ps onwards is higher than the other two systems by almost 300 kJ mol -1 , and this is consistent with the general requirement that an agonist is required for activation since the large energy difference would ensure that only a small proportion of the receptors were in the active form. Figure 3c shows that the energy of the 5,6-domain swapped dimer is significantly lowered (relative to the other structures) in the presence of agonist. This is consistent with the idea that the agonist functions by shifting the equilibrium in favour of the active form, here proposed to be the 5,6-domain swapped dimer. It is dangerous to assume that these energies have any quantitative significance because molecular mechanics energies are relative rather than absolute and because the treatment of solvation is only partial. Because the energies are relative, it is possible to compare energies within a figure (e.g. within Figure 3a) but it is not possible to compare energies between figures-thus it is not valid to compare energies of the antagonist and agonistbound dimers in Figures 3b and c . However, a number of general conclusions may be made and here we will discuss how these relate to our understanding of G-protein coupled receptor activation.
For example, the results are not inconsistent with the idea that the low level of intrinsic activity in the absence of ligand could arise from the small equilibrium concentration of the 5,6-domain swapped dimer. Indeed, the autoactivation of G-protein coupled receptors when overexpressed in transgenic mice (Bond et al., 1995) can be interpreted by assuming that the basal activity of G-protein coupled receptors is related to the rate of dimer formation and that dimer formation is greatly assisted by agonist binding or a higher concentration of receptors. While there is as yet no definitive proof that dimer formation is essential for activation, our results and hypothesis are certainly consistent with Bond's results.
Given the view that agonism follows dimer formation, it is relatively straightforward to explain the activation of receptors by both bivalent antibodies (Leiber et al., 1984) and by antagonists coupled back to back (Hazum and Keinan, 1985) since they will assist in bringing two monomers together. Again, the activation of G-proteins obtained by coupling together two copies of peptides from intracellular loop three (Wade et al., 1994) is consistent with this view of receptor activation as it suggests that the G-protein requires two copies of this loop. [Intracellular loop three connects helices five and six and is essential for activity .] Moreover, this latter observation supports the idea that the active dimer is the 5,6-domain swapped dimer rather than say the 1,2-dimer as observed in the rhodopsin two-dimensional projection maps. The two copies of intracellular loop three are about 70 Å apart in the projection maps while the linker is merely a disulphide bridge. However, the two copies of intracellular loop three move much closer together in the 5,6-domain swapped dimer (by about 40 Å; Gouldson and Reynolds, 1997b) . Ciruela raised antibodies against the second extracellular loop and the third intracellular loop of the A 1 -adenosine receptor (Ciruela et al., 1995) , and so unwittingly provided further evidence for the 5,6-domain swapped dimer. He described identification of both monomers and dimers and their interconversion by agonist or antagonist binding. However, the antibody against the third intracellular loop did not bind to the dimer. If the physiological dimer is indeed a 5,6-domain swapped dimer, then the reasons for this are apparent in the scheme shown in Figure 1 , since the two adjacent copies of intracellular loop three would sterically hinder each other and prevent access by the antibody. The hinge loop between the two domains, i.e. intracellular loop three, is frequently the largest intracellular loop and this will facilitate domain swapping. Maggio et al. (1996) has shown that shortening this loop results in a loss of activity and such behaviour is characteristic of domain swapping.
Structural changes
It is well known throughout computational chemistry that energy changes are difficult to predict to high accuracy but that structural changes can be predicted with more certainty (Williams, 1993) . Indeed, in our monomer-agonist simulations (Gouldson et al., 1997a) we observe very similar structural changes to those of Zhang and Weinstein (1993) and Lou et al. (1994) , namely a twist and vertical displacement of helices five and six resulting in a modest change in their tilt angle. These computational results are consistent with the experimentally derived information on the nature of the agonist-induced conformational change (see for example Gether et al., 1997a Gether et al., , 1995 Javitch et al., 1997) . The ligand induced conformational changes observed here in the dimer are essentially those observed in the monomer (Gouldson et al., 1997a) . Consequently, analysis of the structural changes during the simulations shows that the agonist induced conformational change optimizes the helix-helix packing at the 5,6-dimer interface. Thus, in the 5,6-domain swapped dimer-agonist complex the interfacial helices most readily adopt the optimal packing angle of about 23° (Cohen et al., 1979; Chothia et al., 1981; Sternberg et al., 1982) , though all three dimer structures interact via the required 3-4 interactions. The binding of a second agonist molecule would also affect the tilt angles of helices five and six in the second receptor. However, this would be less favourable as the helix-helix packing at the 5-6 interface would no longer be optimal. This second site in the second receptor could therefore correspond to the low affinity form. These structural changes may also explain the origin of bell-shaped dose response curves which are occasionally observed in G-protein coupled receptors (Järv, 1995) and which are characteristic of dimerization in other systems (De Meyts et al., 1995) since they explain why binding of additional agonist may destabilize the active receptor and result in lower activity. (Bell-shaped dose response curves may also arise for other reasons.)
The simulations show that the antagonist essentially does not affect the helix-helix packing since the antagonist causes only minor conformational changes in both the monomer and the dimer. Consequently, our simulations are consistent with the observation that there is no distinction between high and low affinity forms for antagonist binding. In the monomer simulations (Gouldson et al., 1997a) , the partial agonist pindo-lol causes a change in helix five but not helix six. Consequently, the corresponding 5,6-domain swapped dimer would be stabilized by only one out of a possible two optimal helix packing interactions. Such partially optimized interactions may underlie partial agonism. The high energy of the 1,7-dimer-agonist complex (Figure 3c ) suggests that this species is unlikely to be formed. Consequently, to form the 5,6-domain swapped dimer, the agonist may bind directly to the open form shown in Figure 1 and indeed since the extracellular loops form a tight canopy over the receptor this may be the kinetically preferred route. In addition, the high energy of the 1,7-dimeragonist complex may help to increase the concentration of the active 5,6-domain swapped dimer by preventing the 1,2-dimer (or monomer) from re-forming.
Inspection of Figure 1 and the various dimer structures also allows us to propose a distinction between inverse agonists and antagonists. An inverse agonist would shift the equilibrium away from the 5,6-domain swapped dimer. As such it is likely to favour the formation of monomers, here most closely represented by the 1,2-dimer. Support for this idea comes from the experimental observations of Hebert et al. (1996) for the β 2 -adrenergic receptor which have shown inverse agonists to favour reversal of dimer formation. There is little evidence from Figure 3 that propranolol does this. However, Figure 5 does show that the propranolol-bound dimer residues generally have the highest accessibility.
Buried surface area is often taken as a measure of the strength of a protein-protein interfacial interaction (Stites, 1997) . Figure 5 indicates the residues with the greatest change in buried surface area: residues whose accessibility is less than the average in the 5,6-domain swapped dimer interface include 283 and Leu 287 were all identified as external correlated residues at a level of 0.8 or higher and that Leu 275 , Gly 280 and Gly 284 are conserved or essentially conserved in the adrenergic receptors. Tyr 209 is not in this list, but here the interaction is largely electrostatic rather than due to dispersion/hydrophobic interactions, as discussed below.
For many years, scientists have been puzzled as to why small structural changes to a ligand can cause a switch in behaviour from that of an agonist to that of an antagonist (or vice versa). However, Murray et al. (1995) have shown that the energy difference between monomers and a domain swapped dimer maybe small and that single mutations can have a noticeable effect on this equilibrium. This latter observation probably underlies constitutive activation which can arise in mutated G-protein coupled receptor-see for example the work by Paschke et al. (1994) , Spalding et al. (1997) and Laue (1995) .
Correlated mutation analysis
It may be significant that many of the external correlated mutations (Table IV) lie at the 5-6 interface and that there is a high correspondence with the external residues identified using the spatial, energetic or surface area criteria, as shown in Figures 4 and 5 . The work of Pazos et al. (1997) on over 20 proteins has certainly shown that correlated residues tend to accumulate at inter-domain and inter-protein interfaces. According to Pazos, the Xd descriptor can be used to single out the right inter-domain docking solution from many wrong alternatives. Pazos et al. found (for nine proteins) that a higher Xd was associated with a good docked structure while a more negative Xd was likely to indicate an incorrect structure. Here we have only considered two 'wrong' alternatives (the 1,2-and 1,7-dimers) to the 5,6-domain swapped dimer but since these both have negative Xd values while the 5,6-dimer has a positive Xd value, it appears that a preference for the 5,6-domain dimer is consistent with this analysis. (This analysis is unable to distinguish between a 5,6-contact dimer and a 5,6-domain swapped dimer.) We have also carried out a CMA on the major histocompatibility complex (MHC) class II receptors of the human leucocyte antigen (HLA) and again have observed an accumulation of correlated residues at the protein interface-65% of all correlated residues in HAL DR (23 sequences for the β chains), HLA DP (23 sequences) and HLA DQ (24 sequences) occur at the domain and dimer interfaces (Nilsson,A,. Fernández,N. and Reynolds,C.A., personal communication) . For the human MHC class II receptor there is a crystal structure of the dimer of heterodimers (Jardetzky et al., 1996) but more recently Cherry et al. (1998) have used single particle imaging on living cells and immunochemical techniques on detergent-lysates to follow receptor dimerization on the cell surface and have also shown that the MHC class II receptors form temperature dependent dimers. The evidence is therefore growing that correlated mutations are found at protein interfaces, as suggested by Oliveira et al. (1993) and Horn et al. (1998) .
Some of the adrenergic correlated mutations can be explained by considering the packing effects of the 5-6 interface. The most interesting correlated mutation involves Tyr 209 which has been shown by the calculations to make a strong interaction with helix six through a hydrogen bond to the backbone carbonyl group of Leu 284 . It appears that where Tyr 209 is replaced by Phe, aromatic stacking from the extra Phe at position 287 (which seems to require a smaller valine at position 284) compensates for the loss of hydrogen bonding.
Some researchers may question whether hydrophobic residues alone are able to provide a highly specific dimer interface. Certainly Larsen et al. (1998) in a study of 136 homodimeric proteins found that most protein interfaces were not entirely hydrophobic-unless the dimer was domain swapped (10 cases). In a study of helix-helix interactions in globular proteins, Chothia et al. (1981) observed that half of these interactions were mediated by hydrophobic interactions alone. More significantly, in the glycophorin A dimer, which involves two transmembrane helices, the L 75 IXXGVXXGVXXT 87 motif is responsible for dimerization. This motif is very sensitive to minor changes, such as mutation of Val 84 to Leu or Ile 76 to Ala (Lemmon et al., 1992 (Lemmon et al., , 1994 MacKenzie et al., 1997) but the authors were still able to generate a good model using molecular dynamics. Moreover, these are precisely the kind of changes observed in the external correlated mutations.
The evolutionary trace (ET) method (Lichtage, 1996a (Lichtage, ,b, 1997 has many similarities to correlated mutation analysis and may be used to identify active sites or functional interfaces, as has been shown for G-proteins, SH2 and SH3 domains and for the zinc binding domains of intracellular receptors. Inspection of the sequence alignment and the phylogenetic tree for the adrenergic receptors suggests that a number of conserved and class specific positions lie at the 5-6 interface. For example Phe 208 , Leu 275 and Gly 280 are conserved while Phe 223 and His 269 are essentially class-specific positions at a position identity cut-off (PIC) of 30% while Tyr 209 is a classspecific position at a PIC of 40%. Many of the correlated residues at this interface become class-specific positions at PICs of about 50-60%. The concurrence between these two methods, CMA and ET, provides further evidence that residues at the 5-6 interface have an important function.
The significance of some of the external conserved and correlated residues has been probed by site-directed mutagenesis: mutation of Tyr 205 in the neurokinin NK-1 receptor (Tyr 209 in β 2 -AR) receptor, results in loss of activity (Huang et al., 1994) (this is thought to be an external residue though the authors do not identify it as such). Similar results were obtained for the corresponding Tyr 206 in the neurokinin NK-2 receptor (Huang et al., 1995) . Neither of these mutations affected antagonist binding, and this is consistent with, but not proof of, the idea that the mutation affects helix-helix packing at the dimer interface. Similarly, mutation of Gly 276 , Gly 280 and Leu 284 to alanine in Hebert et al.'s helix six peptide (1996) significantly reduced its ability to inhibit dimerization; again, these correspond to external correlated residues. Because the rotational orientation of each helix in our model is in agreement with much experimental data, including Baldwin's coordinates which are based on Unger's recent experimental projection map , it is likely that the assignment of these external residues is correct. The positive free energy differences recorded in Table III lend support to our receptor model in which these residues lie at the dimer interface.
The correlated mutations on helices one, two and seven may be involved in assisting in the formation of the 1,7-intermediate. There may be data to suggest that helix seven is important in dimerization since mutation of the conserved Trp 313 on the external face of helix seven does result in a small loss of activity (Wess et al., 1993) (Gouldson et al., 1997a ) and its precise location is currently unclear. Ng et al. (1996) have shown that peptides derived from transmembrane helix seven can inhibit dimerization. We propose that the most likely explanation of Ng's observations is that helix seven blocks the activation process by preventing formation of the 1,7-intermediate rather than by binding to the dimer interface. In this context it must be remembered that the helix one-helix seven interaction is probably the weakest as it involves parallel helix dipoles; this is probably an important factor in initiating the domain swapping process.
The correlated mutations were derived independently from the structural model and so the agreement between the two approaches-correlated mutation analysis and homology modelling with simulation-is encouraging, particularly as the role of key residues is supported by site-directed mutagenesis (Huang et al., 1994 (Huang et al., , 1995 Hebert et al., 1996) , free energy simulations and the evolutionary trace method.
Elsewhere we have investigated correlated mutations in a number of other systems, including the dopaminergic and muscarinic receptors and we have again found correlated mutations amongst the external residues of each helix (Gouldson et al., 1997d) . Singer et al. (1995) also found a correlated mutation amongst the external residues of the olfactory receptors (but the significance was not discussed).
Many of the internal correlated residues in the adrenergic, dopaminergic and muscarinic receptors correlate with subtype specificity and indeed mutation of these residues has been shown to switch the ligand binding properties to that of the alternative subtype (Ferenczy et al., 1997; Gouldson et al., 1997e) . Such observations show that correlated mutation analysis does indeed give results which are closely related to experiment, at least in this family of receptors, and gives confidence that the external residues predicted by this technique may indeed have a functional role.
Possible advantages of domain swapping
Given the evidence in favour of the 5,6-domain swapped dimer, it is probably important to ask what are the possible advantages of forming a 5,6-domain swapped dimer as opposed to say a 5,6-contact dimer? Firstly, domain swapping is a very efficient method of forming oligomers since the interactions within the monomer are reused in the oligomer. This principle has been elegantly elucidated by Bennett et al. (1994 Bennett et al. ( , 1995 . Moreover, Tegoni et al. (1996) has shown how domain swapping can be part of a normal activation mechanism. Secondly, the results of Monnot et al. (1996) suggest that domain swapping may also result in the formation of a 4,5-domain swapped dimer. The mechanism in Figure 6 shows how coexpression of an angiotensin II receptor with a fatal mutation on helix three with one containing a fatal mutation on helix five can result in formation of a dimer which regains its ability to bind ligands because the two fatal mutations can be swapped out to generate a seven helix bundle which is fully functional in terms of binding. (The additional energy from the ligand binding process may be the reason why this unusual domain swapped dimer is formed.) However, this receptor is not able to activate G-proteins and a possible explanation for this is that the two copies of the intercellular loops are in the wrong relative orientation (compare Figures  1 and 6 ). Thus, a 5,6-domain swapped dimer may be required to present the two copies of intracellular loop three in the orientation required for G-protein activation. (Thus, we would suggest that coexpression of receptors with fatal mutations on say helix three and helix six would result in receptors able to bind ligands and activate G-proteins.) Finally, domain swapping may be a mechanism for minimizing the effects of loss of function mutations in important receptors provided that two copies of the gene are expressed and that each copy is mutated in a different domain. The phenomena of regaining activity by mixing defective multimeric proteins has been known for a long time (Fincham and Pateman, 1957; Fincham, 1962; Garen and Garen, 1963; Schlesinger and Levinthal, 1963) and 1191 so it is quite plausible that similar mechanisms may occur for domain swapped multidomain proteins.
Conclusions
In summary, a fusion of theoretical and experimental data has been used to investigate the hypothesis that G-protein coupled receptor activation involves receptor dimers. In particular, we have investigated the possibility that the activation process may involve domain swapped dimers. This domain swapping model has provided a useful framework for discussing the molecular events associated with receptor activation. In particular, the results are consistent with the idea that the active, high affinity form of the receptor is a 5,6-domain swapped dimer and that the agonist functions by favouring dimer formation. Our simulations suggest that this is achieved by an agonistinduced conformational change which optimizes the helixhelix interactions at the 5-6 interface. Within this model an antagonist would have no effect on the helix-helix interactions at the dimer interface. An inverse agonist would generate helix-helix interactions which are even less favoured than in the apo-dimer, and would thus shift the equilibrium towards the monomers. Indeed the results for propranolol are not inconsistent with this idea.
The molecular nature of the 5,6-domain swapped dimer has been supported by a correlated mutation analysis through the identification of statistically significant and highly correlated patterns of change amongst the external residues at the 5-6 dimer interface at precisely the locations predicted by the simulations. Site-directed mutagenesis experiments and free energy difference simulations on these residues provides further evidence for the mechanism discussed here, as does the evolutionary trace method. At present the importance of domain swapping in the wider context is not yet known. For example, it is not yet clear whether dimerization is important for all classes of G-protein coupled receptors. For example, the results of Cvejic and Devi (1997) on the opioid receptor suggest that agonist decreases the concentration of dimers. This is in contrast to the work of Hebert et al. (1996) on the β 2 -adrenergic receptor which showed that agonist increased the dimer concentration. There are a number of possible explanations for these differing conclusions. For example, the opioid receptor most likely couples to G i /G o whereas the β 2 -adrenergic receptor couples to G s . Alternatively, since Cvejic and Devi did not carry out any dose response experiments, we cannot rule out the possibility that they are observing the tail end of a bellshaped dose response curve (see Figure 2 of their article) Either way, both groups observe that dimerization is important. It is possible that domain swapped dimers only become important when functional rescue is required and some receptor dimers could perhaps be the substrates for auxiliary enzymes such as kinases (Palczewski and Benovic, 1991) . However, taken together with the other evidence for receptor dimerization presented here, this study offers evidence that dimerization and domain swapping are important events in G-protein coupled receptor activation which certainly merit further experimental and theoretical investigation.
